The global BCG vaccine market size is expected to reach USD 73.02 Million by 2028 at a CAGR of 4.5%, according to the latest report by Reports and Data. Rising prevalence of tuberculosis, increasing investment in R&D for tuberculosis vaccine, and growing caseload of drug resistant tuberculosis are some key factors expected to drive market revenue growth over the forecast period. In addition, increasing demand for BCG vaccines due to increasing number of newborn babies across the globe is also a key factor expected to contribute to market growth going ahead.

BCG, or bacilli Calmette-Guerin, is a vaccine for tuberculosis disease and is commonly given to infants and kids in countries where TB is highly prevalent. BCG vaccine is developed from a weakened strain of tuberculosis bacteria which triggers the immune system to protect against the infection. BCG has been extensively used in countries with high incidence of TB to prevent childhood tuberculosis meningitis and miliary disease. BCG vaccine is generally considered for children who have negative TB test or are continually exposed to untreated or ineffectively treated tuberculosis. BCG vaccine is highly effective against severe forms of TB in children and this has been boosting its demand and is expected to drive market growth going ahead.

However, side effects associated with the vaccine such as high temperature, headache, swollen glands, and soreness at the site of injection can limit the usage of BCG vaccines among certain individuals. In addition, shortage of BCG vaccine supply across the globe can restraint market growth to a certain extent over the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/30

The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.

Key companies operating in the market include:

Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institut.

 The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/30

The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global BCG Vaccine  market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.

On basis of product types and application offered by the BCG Vaccine  industry, the market is segmented into:

Type Outlook (Revenue, USD Million; Volume, Tons, 2018–2028)

  • Immune BCG
  • Therapy BCG

Application Type Outlook (Revenue, USD Million; Volume, Tons, 2018–2028)

  • Hospitals
  • Clinics
  • Others

The regional analysis covers:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • A.E.
    • South Africa
    • Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/bcg-vaccine-market

Benefits of BCG Vaccine  Market Report:

  • Panoramic overview of the opportunities and risks in the BCG Vaccine sector
  • Study of recent innovations and developments in the industry
  • Comprehensive study of the growth pattern of the BCG Vaccine industry
  • In-depth assessment of the competitive landscape of the key players of the BCG Vaccine industry
  • Analysis of the BCG Vaccine market drivers, constraints, and opportunities
  • Assessment of technological developments and latest trends of the industry

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/30

Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.

Browse More Related Reports :

Non-Alcoholic Steatohepatitis (NASH) Market  Companies

Digestive Enzymes Market  Research

Extremities (Shoulder and Small Joint Implants) Market  Growth Rate

Eye Care Product Market Growth

Live Cell Imaging Market  Analysis

Tags: BCG Vaccine Market, BCG Vaccine Market Size, BCG Vaccine Market Share

See Campaign: https://www.reportsanddata.com/report-detail/bcg-vaccine-market
Contact Information:
John W Head of Business Development Reports and Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

Tags:
Reportedtimes, Menafn, PR-Wirein, iCN Internal Distribution, Research Newswire, English

Contact Information:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com